Search Results - "Torim, Yu Yu"

Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis by Teplyakov, A. T., Berezikova, E. N., Shilov, S. N., Popova, A. A., Yakovleva, I. V., Molokov, A. V., Grakova, E. V., Kopeva, K. V., Svarovskaya, A. V., Garmaeva, O. V., Torim, Yu. Yu, Stepachev, E. I., Kalyuzhin, V. V.

“…Aim. To study the link of increased serum concentrations of osteoprotegerin (OPG) in patients with chronic heart failure (CHF) associated with type 2 diabetes…”
Get full text

Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure by A T Teplyakov, E N Berezikova, S N Shilov, E V Grakova, Yu Yu Torim, A V Efremov, I D Safronov, M G Pustovetova, R S Karpov

“…Aim. To study the impact of a polymorphic variant of the matrix metalloproteinase-3 (MMP-3) gene on the development and course of chronic heart failure (CHF)…”
Get full text

Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure by Teplyakov, A T, Berezikova, E N, Shilov, S N, Grakova, E V, Torim, Yu Yu, Efremov, A V, Popova, A A, Pustovetova, M G, Sabirova, A Yu, Kopyeva, K V

“…to reveal the specific features of Fas ligand-mediated ischemic myocardial remodeling and those of chronic heart failure (CHF) development during a 12-month…”
Get full text

EVALUATION OF THE ROLE OF HYPERHOMOCYSTEINEMIA AND POLYMORPHISM C677T GENE OF METHYLTETRAHYDROFOLATEREDUCTASE IN DEVELOPMENT OF CHRONIC HEART FAILURE by Teplyakov, A. T., Berezikova, E. N., Shilov, S. N., Grakova, E. V., Torim, Yu. Yu, Efremov, A. V., Popova, А. А., Pustosvetova, М. G., Sabirova, А. Yu, Kopieva, К. V.

“…Aim. To study the influence of polymorphism of the gene methyltetrahydrofolate-reductase (MTHFR) — polymorhic locus С677Т, and level of homocysteine  in blood…”
Get full text

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ by Ye. N. Berezikova, M. G. Pustovetova, S. N. Shilov, A. V. Yefremov, I. D. Safronov, Ye. N. Samsonova, A. T. Teplyakov, Yu. Yu. Torim, R. Ye. Tuleutaeva

“…Оценена взаимосвязь уровня растворимого Fas-лиганда (sFas-L) в сыворотке крови с тяжестью и характером течения хронической сердечной недостаточности (ХСН) у…”
Get full text

Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment by Tepliakov, A T, Shilov, S N, Berezikova, E N, Efremov, A V, Safronov, I D, Pustovetova, M G, Maianskaia, S D, Torim, Iu Iu, Karpov, R S

“…Aim of investigation - to study effect of angiotensin-converting enzyme (ACE) gene polymorphism as a dominant risk factor of development of chronic heart…”
Get more information

ЦИТОКИНОВЫЙ ПРОФИЛЬ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ by Ye. N. Berezikova, M. G. Pustovetova, S. N. Shilov, A. V. Yefremov, I. D. Safronov, Ye. N. Samsonova, A. T. Teplyakov, Yu. Yu. Torim

“…Оценена взаимосвязь цитокинов интерлейкина-1 и рецепторного антагониста интерлейкина-1 с тяжестью и характером течения хронической сердечной недостаточности у…”
Get full text

Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure by Tepliakov, A T, Shilov, S N, Berezikova, E N, Efremov, A V, Safronov, I D, Pustovetova, M G, Maianskaia, S D, Torim, Iu Iu, Karpov, R S

“…To study the impact of angiotensinogen (AGT) and angiotensin II receptor type 1 (AGTR1) gene polymorphisms on the development and course of chronic heart…”
Get full text

Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study by A T Teplyakov, Yu Yu Torim, A V Kuznetsova, E V Rybal'chenko, A L Krylov, R S Karpov, E V Rybalchenko

“…Aim. To study long-term results of 3-42-month (mean 18.1 ± 1.2 month) of a prospective clinically and angiologically controlled follow-up after coronary…”
Get full text

Impact of Gly389Arg 1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol by Aleksandr Trofimovich Teplyakov, Sergey Nikolaevich Shilov, Ekaterina Nikolaevna Berezikova, Yuliya Yur'evna Torim, Anatoliy Vasil'evich Efremov, Igor' Dmitrievich Safronov, S D Mayanskaya, Anna Aleksandrovna Popova, Elena Nikolaevna Voronina, Rostislav Sergeevich Karpov, A T Teplyakov, S N Shilov, E N Berezikova, Yu Yu Torim, A V Efremov, I D Safronov, S D Mayanskaya, A A Popova, E N Voronina, R S Karpov

“…Aim. To study в1-adrenoceptor gene (ADRB1) polymorphism on the development and course of chronic heart failure (CHF) and on the efficiency of its treatment…”
Get full text

Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure by Teplyakov, A T, Berezikova, E N, Shilov, S N, Grakova, E V, Torim, Yu Yu, Efremov, A V, Safronov, I D, Pustovetova, M G, Karpov, R S

“…To study the impact of a polymorphic variant of the matrix metalloproteinase-3 (MMP-3) gene on the development and course of chronic heart failure (CHF) in…”
Get more information